Literature DB >> 8148435

A comparison of cognitive behavioral treatment for chronic fatigue syndrome and primary depression.

F Friedberg1, L B Krupp.   

Abstract

To evaluate the effect of cognitive behavioral intervention on chronic fatigue syndrome (CFS), we studied three patient groups: a CFS-treatment group (n = 22), a primary depression-treatment group (n = 20), and a no-treatment control group of subjects with CFS (n = 22). For the CFS-treatment group, a trend toward reduced depression-symptom scores was noted, but there were no significant changes in stress-related symptoms or fatigue severity. For the most depressed treated subjects with CFS, significant score reductions were observed in measures of depression, stress, fatigue severity, and fatigue-related thinking. In the depression group, significant reductions in depression, stress, and fatigue severity scores were found. No significant changes in any measure were observed in the CFS control group. A new fatigue-related cognitions scale, developed to assess cognitive and emotional reactions to fatigue, showed a significant reduction in such reactions in the CFS-treatment group, a finding suggesting that depression in this group was mediated by maladaptive thinking. The results suggest that a subset of CFS patients with cognition-related depressive symptomatology may respond to short-term behavioral intervention.

Entities:  

Mesh:

Year:  1994        PMID: 8148435     DOI: 10.1093/clinids/18.supplement_1.s105

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  20 in total

Review 1.  Fatigue in multiple sclerosis: definition, pathophysiology and treatment.

Authors:  Lauren B Krupp
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

Review 2.  Chronic fatigue syndrome: the need for subtypes.

Authors:  Leonard A Jason; Karina Corradi; Susan Torres-Harding; Renee R Taylor; Caroline King
Journal:  Neuropsychol Rev       Date:  2005-03       Impact factor: 7.444

3.  Approaching recovery from myalgic encephalomyelitis and chronic fatigue syndrome: Challenges to consider in research and practice.

Authors:  Andrew R Devendorf; Carly T Jackson; Madison Sunnquist; Leonard A Jason
Journal:  J Health Psychol       Date:  2017-11-28

4.  Prognosis in chronic fatigue syndrome: a prospective study on the natural course.

Authors:  J H Vercoulen; C M Swanink; J F Fennis; J M Galama; J W van der Meer; G Bleijenberg
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-05       Impact factor: 10.154

5.  Randomized, double blind, controlled placebo-phase in trial of low dose phenelzine in the chronic fatigue syndrome.

Authors:  B H Natelson; J Cheu; J Pareja; S P Ellis; T Policastro; T W Findley
Journal:  Psychopharmacology (Berl)       Date:  1996-04       Impact factor: 4.530

6.  Perceived Fatigue Interference and Depressed Mood: Comparison of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis Patients with Fatigued Breast Cancer Survivors.

Authors:  Daniel L Hall; Michael H Antoni; Emily G Lattie; Devika R Jutagir; Sara J Czaja; Dolores Perdomo; Suzanne C Lechner; Jamie M Stagl; Laura C Bouchard; Lisa M Gudenkauf; Lara Traeger; MaryAnn Fletcher; Nancy G Klimas
Journal:  Fatigue       Date:  2015

Review 7.  Association of catastrophizing and fatigue: a systematic review.

Authors:  Nada Lukkahatai; Leorey N Saligan
Journal:  J Psychosom Res       Date:  2012-12-02       Impact factor: 3.006

8.  Memory for fatigue in chronic fatigue syndrome: relationships to fatigue variability, catastrophizing, and negative affect.

Authors:  Stephanie J Sohl; Fred Friedberg
Journal:  Behav Med       Date:  2008       Impact factor: 3.104

9.  Longitudinal change in chronic fatigue syndrome: what home-based assessments reveal.

Authors:  Fred Friedberg; Stephanie J Sohl
Journal:  J Behav Med       Date:  2008-12-20

Review 10.  Cognitive behaviour therapy for chronic fatigue syndrome in adults.

Authors:  Jonathan R Price; Edward Mitchell; Elizabeth Tidy; Vivien Hunot
Journal:  Cochrane Database Syst Rev       Date:  2008-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.